يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"de la Rubia, Javier"', وقت الاستعلام: 1.89s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Harvard University ,, 2770412

    العلاقة: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; Ghobrial I., Rodriguez-Otero P., Koh Y., Martinez-Lopez J., Parmar G., Prince M., Quach H., de la Rubia J., Hermansen E., Hungria V., et al., "ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results", CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, 2021; vv_1032021; av_be09d9a7-e1ea-476f-8197-884cf8344e0e; http://hdl.handle.net/20.500.12627/173933Test; 21

  2. 2
    تقرير

    المساهمون: 137578

    العلاقة: Dimopoulos M. A. , De Samblanx H. M. , Roussou M. G. , Zervas K., Katodritou E., Sargin D., Hulin C., Ahlberg L., De La Rubia J., Ganguly R., et al., "Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.", 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 4 - 07 Aralık 2010, cilt.116, ss.1247-1248; vv_1032021; av_7eb09f26-2a76-4f39-a404-b3f0b98be9a7; http://hdl.handle.net/20.500.12627/86491Test; 116

  3. 3
    دورية أكاديمية

    المساهمون: İstanbul Üniversitesi ,, 257704

    العلاقة: EUROPEAN JOURNAL OF HAEMATOLOGY; Terpos E., Katodritou E., de la Rubia J., Hungria V., Hulin C., Roussou M., Delforge M., Bries G., Stoppa A., Aagesen J., et al., "Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice", EUROPEAN JOURNAL OF HAEMATOLOGY, cilt.101, ss.556-565, 2018; vv_1032021; av_dd9e9334-2cc6-4832-82cb-a0a849885dfc; http://hdl.handle.net/20.500.12627/146016Test; https://doi.org/10.1111/ejh.13147Test; 101; 556; 565